These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12005271)

  • 1. Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
    Dodick DW
    Headache; 2002 Jan; 42(1):21-7. PubMed ID: 12005271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intervention with almotriptan improves sustained pain-free response in acute migraine.
    Mathew NT
    Headache; 2003; 43(10):1075-9. PubMed ID: 14629242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine.
    Mondell BE
    Clin Ther; 2003 Feb; 25(2):331-41. PubMed ID: 12749502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
    Spierings EL; Gomez-Mancilla B; Grosz DE; Rowland CR; Whaley FS; Jirgens KJ
    Arch Neurol; 2001 Jun; 58(6):944-50. PubMed ID: 11405809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
    Mathew NT;
    Headache; 2002 Jan; 42(1):32-40. PubMed ID: 12005273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
    Dowson AJ; Massiou H; Laínez JM; Cabarrocas X
    Cephalalgia; 2002 Jul; 22(6):453-61. PubMed ID: 12133045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials.
    Mathew NT
    Headache; 2002 Jan; 42 Suppl 1():32-7. PubMed ID: 11966862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of almotriptan in controlled clinical trials.
    Mathew NT
    Eur Neurol; 2005; 53 Suppl 1():29-33. PubMed ID: 15920335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.
    Colman SS; Brod MI; Krishnamurthy A; Rowland CR; Jirgens KJ; Gomez-Mancilla B
    Clin Ther; 2001 Jan; 23(1):127-45. PubMed ID: 11219473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of subcutaneous almotriptan for the treatment of acute migraine: a randomized, double-blind, parallel-group, dose-finding study.
    Cabarrocas X;
    Clin Ther; 2001 Nov; 23(11):1867-75. PubMed ID: 11768838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis.
    Cady R
    Headache; 2002 Jan; 42 Suppl 1():26-31. PubMed ID: 11966861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.